Stellingwerff, Menno D.
van de Wiel, Mark A.
van der Knaap, Marjo S.
Article History
Received: 12 September 2022
Accepted: 25 November 2022
First Online: 27 December 2022
Compliance with ethical standards
:
: MSvdK receives research funding from NWO (Spinoza award), ZonMw (TOP 91217006 and 10140261910004/80–86600-98–84001), Hersenstichting (DR-2019–00285), and European Leukodystrophy Foundation (2019-P001 and 2020-017I2). She has a patent P112686CA00, therapeutic effects of Guanabenz treatment in vanishing white matter, pending to VU University Medical Center. MDS and MAvdW declare no competing interests.
: The local ethics committee approved this retrospective study.
: Informed consent was obtained from patients and/or parents.